Leaflet ACID ALENDRONIC/COLECALCIFEROL ACCORD 70mg / 5600UI tablets

Indicated for: osteoporosis

Route of administration: oral

Substance: alendronic acid + cholecalciferol (bisphosphonate + vitamin)

ATC: M05BB03 (Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates, combinations)

Precautions:
Take on an empty stomach
Take on an empty stomach

Take this medicine on an empty stomach.

Avoid milk, calcium, iron, or antacids
Avoid milk, calcium, iron, or antacids

Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.

The combination of alendronic acid and colecalciferol (vitamin D3) is used for the prevention and treatment of osteoporosis, particularly in postmenopausal women or individuals at high risk of bone fractures. This combination helps maintain bone health by reducing bone loss and increasing bone density.

- Alendronic acid is a bisphosphonate that inhibits bone resorption by reducing the activity of osteoclasts (cells that break down bone). This helps prevent bone loss and strengthens bones.
- Colecalciferol (vitamin D3) enhances calcium absorption in the intestines and contributes to its effective utilization in the body, which is essential for bone health.

This combination is typically taken once a week, in the morning, on an empty stomach with a full glass of water. It is important to remain upright for at least 30 minutes after taking it to prevent esophageal irritation. Long-term use should be monitored by a doctor to avoid side effects such as gastrointestinal issues or hypercalcemia.

General data about ACID ALENDRONIC/COLECALCIFEROL ACCORD 70mg / 5600UI

  • Substance: alendronic acid + cholecalciferol
  • Date of latest medicines list: 01-08-2023
  • Product code: W65841001
  • Concentration: 70mg / 5600UI
  • Pharmaceutical form: tablets
  • Quantity: 4
  • Product type: Generic medicine
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: PHARAMATHEN INTERNATIONAL S.A. - GRECIA
  • Holder: ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA
  • Number: 11488/2019/01
  • Shelf life: 2 years

Concentrations available for alendronic acid + cholecalciferol

  • 70mg/2800UI
  • 70mg/5600UI